Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Chronic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00495391
What this trial is testing

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C

Who this might be right for
Chronic Hepatitis C
Romark Laboratories L.C. 64
Not applicableStudy completedNCT04610762
What this trial is testing

HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels

Who this might be right for
Hepatitis C, Chronic
Centre Hospitalier Universitaire Saint Pierre 103
Not applicableStudy completedNCT00705224
What this trial is testing

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus
Merck Sharp & Dohme LLC 250
Not applicableStudy completedNCT02636608
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Hungary

Who this might be right for
Chronic Hepatitis C
AbbVie 244
Testing effectiveness (Phase 2)Study completedNCT00277238
What this trial is testing

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
Hepatitis, Chronic Active
Pfizer 113
Post-approval studies (Phase 4)Looking for participantsNCT03855917
What this trial is testing

Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir

Who this might be right for
Hepatitis C
Kirby Institute 30
Testing effectiveness (Phase 2)Study completedNCT01717326
What this trial is testing

The Combination Regimen Grazoprevir (MK-5172) and Elbasvir (MK-8742) ± Ribavirin in Participants With Chronic Hepatitis C (MK-5172-035)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 573
Large-scale testing (Phase 3)WithdrawnNCT01590225
What this trial is testing

Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)

Who this might be right for
Chronic Hepatitis C
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT02850289
What this trial is testing

APPROACH Study: Quality of Life and Outcomes Assessment in Participants With Chronic Hepatitis C (CHC) Treated With Pegylated Interferon (PEG-IFN) Alfa-2a and Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 385
Not applicableUnknownNCT00160940
What this trial is testing

Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis

Who this might be right for
Hepatitis CHepatitis BAutoimmune Hepatitis+2 more
University Health Network, Toronto 200
Testing effectiveness (Phase 2)Study completedNCT01355289
What this trial is testing

Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501

Who this might be right for
Thrombocytopenia
Eisai Inc. 65
Post-approval studies (Phase 4)Study completedNCT02220868
What this trial is testing

Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study

Who this might be right for
Hepatitis C InfectionHIV Infection
Saint Michael's Medical Center 10
Post-approval studies (Phase 4)Study completedNCT00553930
What this trial is testing

Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients

Who this might be right for
Hepatitis C, ChronicHIV Infections
Sociedad Andaluza de Enfermedades Infecciosas 71
Post-approval studies (Phase 4)Study completedNCT01429792
What this trial is testing

A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin)

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 1,013
Large-scale testing (Phase 3)Study completedNCT02576314
What this trial is testing

Sofosbuvir Containing Regimens for the Treatment of Chronic HCV GT3 Infected Patients

Who this might be right for
Chronic Hepatitis C Infection
Humanity and Health Research Centre 48
Testing effectiveness (Phase 2)Study completedNCT02993250
What this trial is testing

Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus Infection, With or Without Compensated Cirrhosis Who Are Direct Acting Antiviral Treatment-naive

Who this might be right for
Hepatitis C, Chronic
Janssen Pharmaceutical K.K. 33
Large-scale testing (Phase 3)Study completedNCT02640482
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 304
Not applicableUnknownNCT03461250
What this trial is testing

Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational Study

Who this might be right for
HCV Infection
Asociacion para el Estudio del Higado 293
Testing effectiveness (Phase 2)UnknownNCT00332176
What this trial is testing

Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
BioWest Therapeutics Inc 50
Testing effectiveness (Phase 2)Study completedNCT02765490
What this trial is testing

Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 365
Next Page